Published in Prev Chronic Dis on June 15, 2011
Preventing skin cancer through reduction of indoor tanning: current evidence. Am J Prev Med (2013) 0.86
Tanning bed use and melanoma: Establishing risk and improving prevention interventions. Prev Med Rep (2016) 0.75
Youth and tanning: a dangerous combination. J Adv Pract Oncol (2013) 0.75
Skin cancer risk behaviors: a conceptual framework for complex behavioral change. Arch Dermatol (2005) 18.15
Compliance with youth access regulations for indoor UV tanning. Arch Dermatol (2005) 6.29
The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review. Int J Cancer (2007) 3.50
Use of sunscreen, sunburning rates, and tanning bed use among more than 10 000 US children and adolescents. Pediatrics (2002) 3.12
Prevalence and correlates of indoor tanning among US adults. J Am Acad Dermatol (2008) 1.79
Enforcement of state indoor tanning laws in the United States. Prev Chronic Dis (2008) 1.11
Compliance with federal and state legislation by indoor tanning facilities in San Diego. J Am Acad Dermatol (2001) 1.08
Indoor ultraviolet tanning and skin cancer: health risks and opportunities. Curr Opin Oncol (2009) 1.02
A case for informed consent? Indoor UV tanning facility operator's provision of health risks information (United States). Cancer Causes Control (2005) 0.92
Epidemiology of gastric cancer. World J Gastroenterol (2006) 7.67
Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst (2007) 4.97
Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA (2013) 4.67
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol (2010) 4.43
Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA (2004) 4.31
Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst (2003) 3.71
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat (2010) 3.35
Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol (2005) 3.02
Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev (2002) 2.83
The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy. Gastrointest Endosc (2011) 2.73
The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat (2002) 2.71
Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol (2007) 2.69
Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer. J Clin Oncol (2012) 2.59
Use of the Internet by women with breast cancer. J Med Internet Res (2003) 2.46
Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer (2006) 2.36
Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat (2006) 2.26
Prostate cancer in fathers with fewer male offspring: the Jerusalem Perinatal Study cohort. J Natl Cancer Inst (2007) 2.24
Trends in relative survival for ovarian cancer from 1975 to 2011. Obstet Gynecol (2015) 2.22
Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer. J Clin Oncol (2012) 2.21
Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol (2005) 2.11
Epidemiology of upper gastrointestinal malignancies. Semin Oncol (2004) 2.10
Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol (2011) 2.10
Electric blanket use and breast cancer on Long Island. Epidemiology (2003) 2.06
Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol (2013) 2.05
Socioeconomic and other predictors of colonoscopy preparation quality. Dig Dis Sci (2010) 2.04
Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol (2005) 2.03
The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a Surveillance, Epidemiology, and End Results analysis. J Neurosurg (2013) 2.01
Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol (2012) 1.98
Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Biomarkers Prev (2004) 1.96
Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med (2002) 1.89
Lifetime alcohol intake and breast cancer risk. Ann Epidemiol (2005) 1.85
Risk of malignancy in patients with celiac disease. Am J Med (2003) 1.85
Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol (2008) 1.83
Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer (2005) 1.78
Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys (2006) 1.77
High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital charges. Eur Urol (2006) 1.76
Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol (2009) 1.76
Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.73
Trends in hospital volume and patterns of referral for women with gynecologic cancers. Obstet Gynecol (2013) 1.72
Colonoscopic screening in average-risk individuals ages 40 to 49 vs 50 to 59 years. Gastroenterology (2008) 1.71
Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer (2009) 1.70
Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst (2003) 1.68
Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis. J Clin Oncol (2002) 1.68
Internet use and social support in women with breast cancer. Health Psychol (2002) 1.67
Defining the limits of radical cytoreductive surgery for ovarian cancer. Gynecol Oncol (2011) 1.66
Lung cancer risk in white and black Americans. Ann Epidemiol (2003) 1.63
Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol (2008) 1.61
Diabetes mellitus and the risk of prostate cancer. Cancer Invest (2002) 1.60
Effect of surgical volume on outcomes for laparoscopic hysterectomy for benign indications. Obstet Gynecol (2012) 1.58
Incidence and predictors of bowel obstruction in elderly patients with stage IV colon cancer: a population-based cohort study. JAMA Surg (2013) 1.57
Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Ann Intern Med (2006) 1.57
Health belief model factors in mammography screening: testing for interactions among subpopulations of Caribbean women. Ethn Dis (2005) 1.55
Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstet Gynecol (2012) 1.55
Effect of a patient navigator program on the volume and quality of colonoscopy. J Clin Gastroenterol (2011) 1.54
Prior endoscopy in patients with newly diagnosed celiac disease: a missed opportunity? Dig Dis Sci (2013) 1.53
Implementing and evaluating a school-based program to improve childhood vision. J Sch Health (2010) 1.52
Prostate cancer screening behavior in men from seven ethnic groups: the fear factor. Cancer Epidemiol Biomarkers Prev (2006) 1.52
Cardiovascular Disease Mortality Among Breast Cancer Survivors. Epidemiology (2016) 1.52
Fruits, vegetables, and micronutrients in relation to breast cancer modified by menopause and hormone receptor status. Cancer Epidemiol Biomarkers Prev (2004) 1.52
Adherence to biopsy guidelines increases celiac disease diagnosis. Gastrointest Endosc (2011) 1.52
Choline metabolism and risk of breast cancer in a population-based study. FASEB J (2008) 1.51
Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev (2002) 1.50
Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 1.48
Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev (2002) 1.48
Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health (2006) 1.48
Variation in ovarian conservation in women undergoing hysterectomy for benign indications. Obstet Gynecol (2013) 1.46
Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York. Am J Epidemiol (2005) 1.46
Environmental tobacco smoke and breast cancer incidence. Environ Res (2004) 1.45
Improving organochlorine biomarker models for cancer research. Cancer Epidemiol Biomarkers Prev (2005) 1.44
Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis. J Clin Oncol (2002) 1.44
Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomarkers Prev (2009) 1.44
Hospital information systems and clinical cancer research. Cancer Invest (2004) 1.44
Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila) (2009) 1.44
Review and analysis of evaluation measures used in nutrition education intervention research. J Nutr Educ Behav (2002) 1.43
One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res (2005) 1.38
The contribution of emotional characteristics to breast cancer screening among women from six ethnic groups. Prev Med (2004) 1.36
Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study. J Clin Oncol (2002) 1.34
Barriers to colorectal cancer screening with fecal occult blood testing in a predominantly minority urban population: a qualitative study. Am J Public Health (2003) 1.33
Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat (2010) 1.31
Reproductive factors and breast cancer risk among older women. Breast Cancer Res Treat (2006) 1.30
Measuring comparative risk perceptions in an urban minority population: the risk perception survey for diabetes. Diabetes Educ (2007) 1.29
Telephone intervention to promote diabetic retinopathy screening among the urban poor. Am J Prev Med (2008) 1.29
Associations between perceived cancer risk and established risk factors in a national community sample. Cancer Detect Prev (2004) 1.26
Multiple genetic variants in telomere pathway genes and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2010) 1.23
Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients. Breast Cancer Res Treat (2011) 1.22
Estrogen metabolism and breast cancer. Epidemiology (2006) 1.22
Factors associated with colorectal cancer screening among Chinese-Americans. Prev Med (2004) 1.22
Racial/ethnic differences and potential psychological benefits in use of the internet by women with breast cancer. Psychooncology (2003) 1.22
Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy. Clin Gastroenterol Hepatol (2007) 1.21
Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysis. Arch Environ Health (2004) 1.21
DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB J (2012) 1.21
Quality of perioperative venous thromboembolism prophylaxis in gynecologic surgery. Obstet Gynecol (2011) 1.21
Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer (2003) 1.21
Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 1.21
Colon cancer screening practices in New York City, 2003: results of a large random-digit dialed telephone survey. Cancer (2005) 1.21
Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer. Cancer (2007) 1.19
Fruits, vegetables, and micronutrient intake in relation to breast cancer survival. Breast Cancer Res Treat (2006) 1.19
Dating the rise of esophageal adenocarcinoma: analysis of Connecticut Tumor Registry data, 1940-2007. Cancer Epidemiol Biomarkers Prev (2010) 1.19
Barriers to minority participation in breast carcinoma prevention trials. Cancer (2005) 1.18